CION Ameerpet
A diagnosis of leptomeningeal metastasis, or carcinomatous meningitis, is frightening and often confusing. This page explains it in plain words. Our tumour board reviews every patient to find gentle, evidence-based options.
Leptomeningeal metastasis — also called carcinomatous meningitis or leptomeningeal disease — happens when cancer cells travel into the leptomeninges, the delicate membranes and the cerebrospinal fluid (CSF) that surround the brain and spinal cord. Because this fluid flows around the entire nervous system, the cancer cells can settle in many places at once — the brain, the nerves that control the face and eyes, and the spine.
This is a form of secondary cancer. It is not a tumour that began in the brain. The cells originated in a cancer elsewhere in the body and then spread. It is related to, but different from, solid brain metastases — where deposits form as lumps in the brain tissue rather than spreading through the fluid. Some people have both at the same time.
According to the EANO–ESMO clinical practice guideline on leptomeningeal metastasis, diagnosis rests on a combination of the clinical picture, MRI of the brain and spine with contrast, and cerebrospinal fluid analysis — and a single negative CSF cytology does not rule the disease out, which is why testing is sometimes repeated.
The most telling feature of leptomeningeal disease is that several unrelated neurological symptoms appear together, because the disease affects different areas of the nervous system at the same time. In a person with a known cancer, this pattern is the classic warning sign and should prompt urgent review. Common symptoms include:
When to act: If you are living with cancer and develop new neurological symptoms — especially more than one at once — do not wait. Contact your oncology team promptly. Speak to a CION specialist or call 18002028726.
Leptomeningeal metastasis is a complication of an underlying cancer. Knowing where the cancer started matters, because it guides which modern drugs may help. The most common sources among solid tumours are below.
One of the most frequent solid-tumour causes of leptomeningeal disease. If breast cancer is your primary diagnosis, its hormone-receptor and HER2 status shapes the systemic treatment options. Learn more on our breast cancer hub.
Lung adenocarcinoma, especially when it carries certain molecular changes, can spread to the CSF. Some targeted drugs reach the fluid well. See our lung cancer hub for how molecular testing guides therapy.
Advanced melanoma has a known tendency to involve the leptomeninges. Modern immunotherapy has changed what is possible for some patients. More on our skin cancer hub.
Kidney cancer and gastrointestinal cancers can also spread this way. Blood cancers involve the CSF too, though that is usually managed as a separate situation.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centreTravelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationShare your name and number — we'll call you back within 30 minutes to schedule your consultation.
Bring your reports for a free, unhurried second opinion. Our tumour board will explain your options clearly and help you decide the next step — for healing and comfort, not billing.
Confirming leptomeningeal disease takes more than one test, because the cancer cells are spread thinly through the fluid. CION's diagnostic pathway follows NCCN and EANO–ESMO guidance and usually combines the following.
A gadolinium-enhanced MRI of the whole neuraxis — brain and full spine — is the key imaging test. It can show thin enhancement along the surface of the brain, the cranial nerves, or the nerve roots of the spine. Imaging is ideally done before a lumbar puncture, so the puncture does not create changes that confuse the scan.
A small sample of cerebrospinal fluid is drawn through a needle in the lower back and examined for cancer cells (CSF cytology), along with protein, glucose, and pressure. Cytology can be negative even when the disease is present, so guidelines support repeating the test when suspicion is high. Newer molecular and cell-based CSF assays are increasingly used to improve detection.
A diagnosis is made when the clinical symptoms, the MRI, and the CSF are considered together — often confirmed when either the imaging or the fluid is positive. Because you may already have a known primary cancer, your existing scans and pathology reports are an important part of the review. See our brain metastases guide for how solid deposits differ from fluid spread.
There is no single treatment for leptomeningeal metastasis. Care is individualised to your primary cancer, your symptoms, and your overall strength — and the goals are to relieve symptoms, slow the disease, and protect comfort and dignity. CION delivers the following directly, and coordinates the rest with trusted partners.
Focused radiation is used to treat areas causing symptoms — for example a region of spine causing weakness, or a site of bulky disease. Our radiation oncology team plans treatment to target the problem area while protecting healthy tissue, easing pain and pressure.
Drugs given by mouth or into a vein — targeted therapy, immunotherapy, or chemotherapy — are chosen by the biology of your primary cancer. Some modern targeted and immune agents cross into the nervous system and have changed what is possible for certain cancers. Our medical oncologists select therapy by drug class and mechanism, based on your molecular test results.
Some patients benefit from intrathecal therapy — medicine delivered directly into the cerebrospinal fluid, sometimes through a small implanted reservoir. When a device is needed to deliver drugs into the CSF, or to relieve fluid pressure, CION coordinates this with accredited neurosurgical partners while our team manages your systemic and supportive care.
Comfort comes first. Steroids reduce swelling and pressure, anti-seizure and pain medicines control symptoms, and our supportive-care team addresses nausea, fatigue, and emotional wellbeing for you and your family throughout.
Explore CION's full brain tumour treatment approach, or book a free consultation to discuss a plan built around you.
NCCN Central Nervous System Cancers guidelines emphasise that leptomeningeal metastasis management is highly individualised — balancing disease control against quality of life — and that treatment choices depend on a patient's performance status, the extent of disease, and how well the primary cancer responds to systemic therapy.
Leptomeningeal disease is complex, and a fresh review can bring clarity and new options. A second opinion is especially worthwhile in these situations:
CION offers a free written second opinion. Bring your MRI, CSF report, and primary-cancer pathology, and our tumour board will review everything together. Request a free second opinion or call 18002028726.
Start with the Brain Cancer & Tumour hub for the full picture, or reach out directly — we walk this journey with you.
Our tumour board will review your reports and explain your options with honesty and compassion — at no cost, and with no pressure to start treatment.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.Leptomeningeal metastasis is when cancer cells spread into the leptomeninges — the thin membranes and the cerebrospinal fluid (CSF) that bathe the brain and spinal cord. Because the fluid flows everywhere the nervous system reaches, the disease can cause symptoms in the brain, the cranial nerves, and the spine at the same time. It is also called carcinomatous meningitis, leptomeningeal carcinomatosis, or leptomeningeal disease (LMD). It is a form of secondary (metastatic) cancer — the cells came from a tumour elsewhere in the body, most often breast cancer, lung cancer, or melanoma.
Symptoms are often scattered and change quickly, because the disease affects several parts of the nervous system at once. Common leptomeningeal disease symptoms include a new, persistent headache; nausea and vomiting; double vision or a drooping eyelid; facial numbness or weakness; hearing loss; difficulty swallowing; leg weakness; bladder or bowel changes; and confusion or memory problems. A pattern of several unrelated neurological symptoms appearing together, in a person with a known cancer, is the classic warning sign and should prompt urgent review by an oncologist.
Diagnosis usually rests on two tests. First, an MRI of the whole brain and spine with contrast, which can show enhancement of the meninges or nerve roots. Second, a lumbar puncture to sample the cerebrospinal fluid, which is examined for cancer cells (CSF cytology). One negative CSF sample does not rule the disease out — guidelines note cytology may need repeating. Newer CSF tests, including cell-based and molecular assays, are increasingly used. Diagnosis is confirmed when either the MRI or the CSF is positive alongside a suggestive clinical picture.
The solid tumours that most commonly cause leptomeningeal metastasis are breast cancer, lung cancer (especially adenocarcinoma), and melanoma. Kidney cancer and gastrointestinal cancers can also spread this way. Blood cancers such as leukaemia and some lymphomas involve the CSF too, though that is usually described separately. Because the primary cancer type guides which drugs may help, confirming where the cancer started is a key part of planning care.
Treatment is individualised and focuses on controlling the disease and protecting quality of life. Options, used alone or together, include radiation therapy to symptomatic areas, systemic therapy (chemotherapy, targeted therapy, or immunotherapy chosen by the primary cancer's biology), and intrathecal therapy — drugs delivered directly into the CSF. Steroids and anti-seizure medicines control symptoms. When a device to deliver drugs into the CSF or to relieve fluid pressure is needed, CION coordinates this with accredited neurosurgical partners. NCCN and EANO guidelines stress matching the plan to each person's cancer type, symptoms, and overall condition.
Leptomeningeal disease is serious and advanced, and we will always be honest with you about that. But it is not a situation without options. Treatment can ease symptoms, slow progression, and help some people live longer and more comfortably — outcomes vary widely by cancer type and by how well the primary cancer responds to modern targeted and immune therapies. Our tumour board reviews every patient to find the approach that offers the most benefit with the least burden. You deserve a team that walks this journey with you and makes decisions for healing and comfort, not billing.
Disclaimer: This content is intended for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified oncologist for guidance specific to your medical condition. The information on this page is periodically reviewed and updated by CION's medical team in accordance with current clinical guidelines from NCCN and EANO.
Browse our complete guide to brain tumours and brain cancer — symptoms, scans, tumour types, treatment, prognosis and life after treatment. Tap any topic to read more.